Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B

SHANG-CHIN HUANGTUNG-HUNG SUTAI-CHUNG TSENGCHI-LING CHENSHIH-JER HSUSIH-HAN LIAOCHUN-MING HONGCHEN-HUA LIUTING-YUAN LANHUNG-CHIH YANGCHUN-JEN LIUPEI-JER CHENJIA-HORNG KAO2023-06-132023-06-132023-05-291936-0533https://scholars.lib.ntu.edu.tw/handle/123456789/632646Chronic hepatitis B (CHB) and metabolic dysfunction-associated fatty liver disease (MAFLD) are the leading causes of hepatocellular carcinoma (HCC). We aim to explore the impact of concurrent MAFLD on the risk of HCC in CHB.enHepatitis B virus (HBV); Liver cancer; Metabolic dysfunction-associated fatty liver disease (MAFLD); Metabolic syndrome; Non-alcoholic fatty liver disease (NAFLD)[SDGs]SDG3Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis Bjournal article10.1007/s12072-023-10545-6372470452-s2.0-85160397101WOS:000996368200001